Arch Therapeutics, Inc.
ARTH
$0.1574
-$0.0426-21.30%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 30.90K | 31.90K | 45.90K | 39.50K | 13.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.90K | 31.90K | 45.90K | 39.50K | 13.30K |
| Cost of Revenue | 21.10K | 21.60K | 23.60K | 23.30K | 18.50K |
| Gross Profit | 9.80K | 10.30K | 22.30K | 16.20K | -5.20K |
| SG&A Expenses | 875.60K | 683.20K | 1.31M | 1.15M | 870.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.05M | 908.60K | 1.54M | 1.37M | 1.03M |
| Operating Income | -1.02M | -876.70K | -1.49M | -1.33M | -1.01M |
| Income Before Tax | -5.65M | -1.47M | -2.68M | -2.46M | -1.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.65M | -1.47M | -2.68M | -2.46M | -1.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.65M | -1.47M | -2.68M | -2.46M | -1.82M |
| EBIT | -1.02M | -876.70K | -1.49M | -1.33M | -1.01M |
| EBITDA | -1.02M | -876.20K | -1.49M | -1.33M | -1.01M |
| EPS Basic | -1.44 | -0.33 | -0.57 | -0.29 | -1.42 |
| Normalized Basic EPS | -0.80 | -0.20 | -0.36 | -0.18 | -0.89 |
| EPS Diluted | -1.44 | -0.33 | -0.57 | -0.29 | -1.42 |
| Normalized Diluted EPS | -0.80 | -0.20 | -0.36 | -0.18 | -0.89 |
| Average Basic Shares Outstanding | 4.44M | 4.50M | 4.71M | 8.50M | 1.28M |
| Average Diluted Shares Outstanding | 4.44M | 4.50M | 4.71M | 8.50M | 1.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
